Partnership integrates Scipher’s PrismRA to deliver insights into therapy response segmentation Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights,
Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease Illumina Inc. and Tempus AI, Inc. a technology company leading
Signios Biosciences , a science-first biotechnology company at the forefront of multiomics and AI-powered bioinformatics, announced its rebranding from its previous identity as the US
A novel approach to disease prevention and treatment, precision medicine—also referred to as “personalized medicine”—considers variations in people’s genes, environments, and lifestyles. Using biomarkers to separate patients in clinical trials to improve effectiveness and/or
Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Proscia,
MSInsight, an innovative start-up specializing in precision medicine in oncology, announces the successful completion of its €1.6 million seed funding round. This fundraising was carried
Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a multi-year agreement with all Danish healthcare
Renovaro Biosciences Inc., a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, announced a definitive agreement to merge with BioSymetrics,
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial intelligence (AI)-enabled prognostic and predictive tests
Fuel up with free Health Tech Insights
